it would be a gamble if someone was to try take over the company...

it would be a gamble if someone was to try take over the company now, cant see it happening.

good potential, but why take the risk

Vaccine - uncertain
Cardiocel - proven product, but hasn't proven to be market disruptive (maybe as time goes by)
Vascucel - same as Cardiocel.

They tidied up a few loose ends in the last quarter, staffing and regen ownership, that's a plus.
Got the manufacturing process up to scratch.
The above came at a cost, underlying it is good but the last Q still saw $6.8m out the door.
need to show that these 1 off's aren't a recurring. feature for AHZ

So nothing to excite a potential takeover or the share price.

Could be a boring quarter with sp drifting back unless they get some good numbers news. A new pump contract or lightning initial Vascucel sales announcement might do it.

Same old same old for AHZ, always waiting for next Q.